News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
863,401 Results
Type
Article (87550)
Company Profile (827)
Press Release (775005)
Multimedia
Podcasts (179)
Webinars (28)
Section
Business (233106)
Career Advice (4140)
Deals (39813)
Drug Delivery (141)
Drug Development (91287)
Employer Resources (203)
FDA (18301)
Job Trends (17407)
News (397505)
Policy (39931)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (130)
Alliances (56980)
ALS (147)
Alzheimer's disease (1694)
Antibody-drug conjugate (ADC) (269)
Approvals (18343)
Artificial intelligence (518)
Autoimmune disease (107)
Automation (30)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (168)
Biotechnology (485)
Bladder cancer (140)
Brain cancer (53)
Breast cancer (533)
Cancer (4204)
Cardiovascular disease (367)
Career advice (3562)
Career pathing (38)
CAR-T (259)
CDC (57)
Cell therapy (716)
Cervical cancer (33)
Clinical research (75875)
Collaboration (1460)
Company closure (4)
Compensation (970)
Complete response letters (63)
COVID-19 (2966)
CRISPR (85)
C-suite (632)
Cystic fibrosis (142)
Data (5016)
Decentralized trials (2)
Denatured (65)
Depression (115)
Diabetes (470)
Diagnostics (7114)
Digital health (38)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (248)
Drug pricing (196)
Drug shortages (36)
Duchenne muscular dystrophy (210)
Earnings (99460)
Editorial (55)
Employer branding (25)
Employer resources (172)
Events (133623)
Executive appointments (1000)
FDA (20905)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (17)
Funding (1311)
Gene editing (181)
Generative AI (52)
Gene therapy (572)
GLP-1 (1045)
Government (5396)
Grass and pollen (8)
Guidances (374)
Healthcare (20940)
HIV (49)
Huntington's disease (41)
IgA nephropathy (69)
Immunology and inflammation (258)
Immuno-oncology (22)
Indications (60)
Infectious disease (3219)
Inflammatory bowel disease (193)
Inflation Reduction Act (16)
Influenza (104)
Intellectual property (202)
Interviews (816)
IPO (17932)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (82)
Layoffs (643)
Leadership (37)
Legal (10152)
Liver cancer (92)
Longevity (13)
Lung cancer (595)
Lymphoma (289)
Machine learning (33)
Management (66)
Manufacturing (676)
MASH (148)
Medical device (14918)
Medtech (14947)
Mergers & acquisitions (22797)
Metabolic disorders (1209)
Multiple sclerosis (141)
NASH (23)
Neurodegenerative disease (239)
Neuropsychiatric disorders (64)
Neuroscience (2778)
NextGen: Class of 2025 (7707)
Non-profit (5098)
Now hiring (60)
Obesity (584)
Opinion (316)
Ovarian cancer (144)
Pain (173)
Pancreatic cancer (181)
Parkinson's disease (248)
Partnered (32)
Patents (434)
Patient recruitment (344)
Peanut (57)
People (66380)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23402)
Phase II (32925)
Phase III (24829)
Pipeline (3036)
Policy (306)
Postmarket research (3554)
Preclinical (10577)
Press Release (72)
Prostate cancer (207)
Psychedelics (52)
Radiopharmaceuticals (283)
Rare diseases (717)
Real estate (7423)
Recruiting (79)
Regulatory (28168)
Reports (65)
Research institute (2698)
Resumes & cover letters (651)
Rett syndrome (18)
RNA editing (15)
RSV (77)
Schizophrenia (140)
Series A (215)
Series B (160)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4320)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (112)
Vaccines (1067)
Venture capital (69)
Weight loss (413)
Women's health (63)
Worklife (21)
Date
Today (319)
Last 7 days (1272)
Last 30 days (3615)
Last 365 days (33797)
2025 (28937)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1284)
Alabama (81)
Alaska (7)
Arizona (312)
Arkansas (14)
Asia (51091)
Australia (8982)
California (10037)
Canada (2964)
China (958)
Colorado (420)
Connecticut (445)
Delaware (288)
Europe (117453)
Florida (1471)
Georgia (327)
Hawaii (3)
Idaho (67)
Illinois (833)
India (56)
Indiana (493)
Iowa (20)
Japan (339)
Kansas (127)
Kentucky (39)
Louisiana (23)
Maine (80)
Maryland (1335)
Massachusetts (7496)
Michigan (321)
Minnesota (593)
Mississippi (4)
Missouri (124)
Montana (33)
Nebraska (26)
Nevada (110)
New Hampshire (80)
New Jersey (2771)
New Mexico (32)
New York (2692)
North Carolina (1459)
North Dakota (10)
Northern California (4637)
Ohio (310)
Oklahoma (22)
Oregon (51)
Pennsylvania (2066)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (52)
South Dakota (1)
Southern California (3832)
Tennessee (153)
Texas (1566)
United States (36782)
Utah (301)
Virginia (257)
Washington D.C. (84)
Washington State (856)
West Virginia (4)
Wisconsin (104)
Wyoming (2)
There are 863,401 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IRLAB Receives Acceptance for Two Abstracts at AD/PD(TM) 2026: The 20th International Conference on Alzheimer’s and Parkinson’s Diseases
November 7, 2025
·
2 min read
Press Releases
Harbour BioMed and Evinova China Announce Strategic AI Collaboration to Accelerate AI-Enabled Drug Development
November 7, 2025
·
3 min read
Press Releases
Trading Statement Q3-2025: Expanding Our R&D Activities
November 7, 2025
·
8 min read
Press Releases
Memo Therapeutics AG Presents Long Term Follow-Up Data from its Phase II SAFE KIDNEY Trial of Potravitug and Real World Data on the Challenges and Re-source Utilization of Managing Kidney Transplant Recipients at ASN Kidney Week Meeting
November 7, 2025
·
4 min read
Press Releases
Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates
November 7, 2025
·
16 min read
Press Releases
Rezurock® now covered in Quebec for people living with chronic graft-versus-host disease (GVHD)
November 7, 2025
·
4 min read
Press Releases
Mwyngil Therapeutics Announces In-Licensing of GPR75 Modulators and Cell-Surface Discovery Platform from Expert Systems Inc.
November 7, 2025
·
3 min read
Press Releases
Viatris Reports Third Quarter 2025 Results and Updates 2025 Financial Guidance
November 7, 2025
·
45 min read
Press Releases
Lilly’s selective amylin agonist, eloralintide, demonstrated meaningful weight loss and favorable tolerability in a Phase 2 study of adults with obesity or overweight
November 7, 2025
·
7 min read
Press Releases
UroGen Reports 77.8% Three-Month Complete Response Rate from Phase 3 UTOPIA Trial of UGN-103 and Receives FDA Agreement on NDA Submission Strategy in Recurrent LG-IR-NMIBC Based on UTOPIA Trial
November 7, 2025
·
11 min read
1 of 86,341
Next
